President & CEO
Ofstead & Associates, Inc.
Bloomington, Minnesota
Cori L. Ofstead, MSPH, is an epidemiologist with 30 years of experience designing and conducting studies on the impact of clinical processes on patient outcomes. She is the founder and CEO of Ofstead & Associates, Inc., an independent company that specializes in designing and conducting real-world research. She has served as the Principal Investigator on several studies related to infection prevention, vaccination, and instrument reprocessing. Ms. Ofstead is nationally recognized for her outcomes research, and her studies have been published in peer-reviewed journals including AJIC, ICHE, Journal of Hospital infection, CHEST, AORN Journal, Journal of Wound Care, Endoscopy International Open, and Gastroenterology Nursing. She currently serves as a reviewer for AJIC, Endoscopy, Journal of Urology, and Vaccine and is on the editorial board for AJIC.
Monday, June 26, 2023
4:30 PM – 5:30 PM
Disclosure(s): 3M Company: Consultant/Advisory Board (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Advanced Sterilization Products: Consultant/Advisory Board (Ongoing), Other Research Support (Ongoing), Research Grant (Ongoing); Ambu: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Cleanis: Research Grant (Ongoing); Healthmark Industries: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); Ofstead & Associates, Inc.: Employment (full or part time) (Ongoing), Ownership Interest (Ongoing); Pentax: Consultant/Advisory Board (Ongoing); Steris/Cantel/Medivators: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing)